Esketamine: US regulator approves nasal spray to treat depression

Esketamine: US regulator approves nasal spray to treat depression

Esketamine nasal spray can reportedly work within 24 hours, but critics say more tests are needed.

Source: BBCi.co.uk — Read: Original Article

Share this page...
CBDPet CBD Hemp Oil Extract Dietary Supplement

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.